Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3121 AL 3135

[Research progress of the dopamine system in neurological diseases]

Niu YQ, Wang JJ, Cui WF, Qin P, Gao JF.

Sheng Li Xue Bao. 2025 Apr 25;77(2):309-317. doi: 10.13294/j.aps.2025.0025.

Ankle plantar-dorsal flexion exercises mitigate orthostatic hypotension in patients with neurodegenerative diseases

Akiba T, Terayama K, Ogawa A, Teramoto H, Nakajima A.

Int J Rehabil Res. 2025 Sep 1;48(3):157-165. doi: 10.1097/MRR.0000000000000671. Epub 2025 May 6.

Ligands for Protein Fibrils of Amyloid-β, α-Synuclein, and Tau

Chisholm TS, Hunter CA.

Chem Rev. 2025 Jun 11;125(11):5282-5348. doi: 10.1021/acs.chemrev.4c00838. Epub 2025 May 6.

Gene-modified animal models of Parkinson's disease

Peng Y, Jiang DY, Yao SY, Zhang X, Kazuo S, Liu J, Du MQ, Lin LX, Chen Q, Jin H.

Exp Neurol. 2025 Aug;390:115287. doi: 10.1016/j.expneurol.2025.115287. Epub 2025 May 4.

Efficacy of botulinum neurotoxin-A in the treatment of neuropsychiatric symptoms in patients with Parkinson's disease: an open-label randomized controlled study

Zhu X, Yang X, Wei M, Wang H, Shen J, Han Q.

Expert Rev Neurother. 2025 Jun;25(6):717-725. doi: 10.1080/14737175.2025.2500753. Epub 2025 May 6.

AI-assisted ophthalmic imaging for early detection of neurodegenerative diseases

Tukur HN, Uwishema O, Akbay H, Sheikhah D, Correia IFS.

Int J Emerg Med. 2025 May 6;18(1):90. doi: 10.1186/s12245-025-00870-y.

Curcumin as a potential therapeutic agent for Parkinson's disease: a systematic review

Chang YH.

Front Pharmacol. 2025 Apr 22;16:1593191. doi: 10.3389/fphar.2025.1593191. eCollection 2025.

Long-Term Outcomes in a Parkinson's Disease Minor Phenomena Cohort

Schneider RB, Singh A, Weber MT, Elmer AT, Amodeo K, Lizarraga KJ, Richard IH, McDermott MP.

Mov Disord Clin Pract. 2025 Oct;12(10):1520-1527. doi: 10.1002/mdc3.70121. Epub 2025 May 7.

Transcranial magnetic resonance imaging-guided focused ultrasound for neuropathic pain treatment

Marino S, Le Cause M, De Salvo S, Cardia L, Corallo F, Anfuso C, Di Lorenzo G, Morabito R, Cammaroto S, Smorto C, Militi A, Sorbera C, Brigandì A, Maugeri R, Lavano A, Quartarore A, La Torre D.

Expert Rev Med Devices. 2025 May;22(5):455-465. doi: 10.1080/17434440.2025.2485289. Epub 2025 May 7.

The device-aided intrajejunal delivery of levodopa-entacapone-carbidopa intestinal gel the treatment of Parkinson's disease: overview of efficacy and safety

Popławska-Domaszewicz K, Metta V, Odin P, Chaudhuri KR.

Expert Rev Med Devices. 2025 Jun;22(6):533-544. doi: 10.1080/17434440.2025.2499153. Epub 2025 May 8.

Changes in proBDNF and Mature BDNF Levels After Medium-Intensity Functional Motor Rehabilitation Program in Patients with Parkinson's Disease

Cholewa J, Nowacka-Chmielewska M, Gorzkowska A, Malecki A, Lasek-Bal A, Cholewa J.

Int J Mol Sci. 2025 Apr 11;26(8):3616. doi: 10.3390/ijms26083616.

Role of Antioxidants in Modulating the Microbiota-Gut-Brain Axis and Their Impact on Neurodegenerative Diseases

Kurhaluk N, Kamiński P, Bilski R, Kołodziejska R, Woźniak A, Tkaczenko H.

Int J Mol Sci. 2025 Apr 12;26(8):3658. doi: 10.3390/ijms26083658.

Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review

Saija C, Currò M, Ientile R, Caccamo D, Bertuccio MP.

Int J Mol Sci. 2025 Apr 13;26(8):3672. doi: 10.3390/ijms26083672.

Obstructive Sleep Apnea and Parkinson's Disease: Bidirectional Clinical and Pathophysiologic Links

Wang JDJ, Chua NYM, Chan LL, Tan EK.

Int J Mol Sci. 2025 Apr 16;26(8):3762. doi: 10.3390/ijms26083762.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias